TERZAH HORTON to Immunoblotting
This is a "connection" page, showing publications TERZAH HORTON has written about Immunoblotting.
Connection Strength
0.086
-
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 01; 13(5):1516-22.
Score: 0.064
-
Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J Virol. 1991 May; 65(5):2629-39.
Score: 0.021